| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/11/2001 | CN1303378A 3-(Amino-or aminoalkyl) pyridinone derivatives and their use for treatment of HIV related diseases |
| 07/11/2001 | CN1303376A Compound with activity on muscarinic receptors |
| 07/11/2001 | CN1303374A Substituted indolinones, production thereof and their use as medicaments |
| 07/11/2001 | CN1303373A N-Aryloxyethylamine derivatives for treatment of depression |
| 07/11/2001 | CN1303372A New heterocyclically substituted amides, their production and their use |
| 07/11/2001 | CN1303370A Prostaglandin derivative |
| 07/11/2001 | CN1303369A Method for making hydroxy-25-ene-vitamin D compounds |
| 07/11/2001 | CN1303368A 1 Alpha-hydroxy-25-ene-vitamin D, analogs and use thereof |
| 07/11/2001 | CN1303367A Nitric oxide synthase inhibitors |
| 07/11/2001 | CN1303365A Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors |
| 07/11/2001 | CN1303364A Aminocyclohexyl ether compounds and uses thereof |
| 07/11/2001 | CN1303302A Minoxidil compositions for external use |
| 07/11/2001 | CN1303297A Treatment of arthritis and other similar conditions |
| 07/11/2001 | CN1303295A Novel synergistic compositions containing aromatic compounds and terpenoids present in alpinia galanga |
| 07/11/2001 | CN1303294A Antitumor agents |
| 07/11/2001 | CN1303293A Process for producing composite preparation containing nucleic acid |
| 07/11/2001 | CN1303292A 睡眠诱发剂 Sleep-inducing agent |
| 07/11/2001 | CN1303291A Sustained-release composition containing cefaclor |
| 07/11/2001 | CN1303290A sPLA Inhibitor ester |
| 07/11/2001 | CN1303289A Adenosine A3 receptor modulators |
| 07/11/2001 | CN1303288A Combination therapy for treatment of tumors |
| 07/11/2001 | CN1303287A Opioid agonist/antagonist combinations |
| 07/11/2001 | CN1303286A Use of cabergoline in treatment of restless legs syndrome |
| 07/11/2001 | CN1303285A Microemulsion preconcentrates containing piperidine substance P antagonist |
| 07/11/2001 | CN1303284A 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5H-benzo[5,6] cyclohepta [1,2-b] pyridine oral compositions |
| 07/11/2001 | CN1303283A Thienylazolylal coxyethanamines, their preparation and their application as medicaments |
| 07/11/2001 | CN1303282A Methods and compositions for reducing UV-induced inhibition of collagen synthesis in human skin |
| 07/11/2001 | CN1303281A Use of compounds for elevation of pyruvate dehydrogenase activity |
| 07/11/2001 | CN1303280A Stable dosage forms of fluoxetine and its enantiomers |
| 07/11/2001 | CN1303279A Topical transdermal treatments |
| 07/11/2001 | CN1303276A Drug delivery system comprising tightly compacted solid medicament stock |
| 07/11/2001 | CN1303272A Preparations for application of anti-inflammatory, especially antiseptic agents and/or agents promoting healing of wounds, to upper respiratory tract and/or ear |
| 07/11/2001 | CN1303271A Preparations for application of anti-inflammatory, especially antiseptic agents and/or agents promoting healing of wounds, to lower respiratory tract |
| 07/11/2001 | CN1303270A 气雾剂组合物 Aerosol composition |
| 07/11/2001 | CN1303269A Anticancer compositions |
| 07/11/2001 | CN1303263A Topital delivery system for active agents |
| 07/11/2001 | CN1303260A Alpha-hydroxy fatty acid derivatives and composition for external use containing same |
| 07/11/2001 | CN1302811A Compound (I), extraction process and its application in preparing medicine to cure acute ischemic cerebrovascular disease |
| 07/11/2001 | CN1302808A Zinc fructose-diphosphate and its preparing process and application |
| 07/11/2001 | CN1302804A Dihydrofuro [3,4-b] quinoline-1-ketone type compound, its preparation method and medicinal composition containing these compounds |
| 07/11/2001 | CN1302800A Method for preparing 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline |
| 07/11/2001 | CN1302663A Substrate tablet containing trimetazidine capable of long time controlled release after oral application |
| 07/11/2001 | CN1302650A 'Hehe' ointment and its preparing process |
| 07/11/2001 | CN1302646A Exterior-applied ointment for lossing weight and its preparing process |
| 07/11/2001 | CN1302616A Powdered medicine for treating simple baby diarrhea |
| 07/11/2001 | CN1302613A Compound pancreatic ribonucleate for injection |
| 07/11/2001 | CN1302612A Preparation method of medicinal composition containing 1,3-oxathin cyclopentane nucleoside analogues |
| 07/11/2001 | CN1302611A Veterinary medicine for treating diseases caused by bacteria and mycoplasma infections |
| 07/11/2001 | CN1302610A Application of emodin-8-0-beta-D-glucoside |
| 07/11/2001 | CN1302609A Phosphonate medicine for treating osteoporosis and bone cancer transfer |
| 07/11/2001 | CN1302608A Clonidine preparation |
| 07/11/2001 | CN1302607A Slow-releasing magnesium propylvalerate tablet and its preparing process |
| 07/11/2001 | CN1302605A Controlled releasing oral medicine composition |
| 07/11/2001 | CN1302599A Cosmetic composition containing N-ethoxycarbonyl-4-amino-phenol and arbutin or its derivative and/or ellagic acid or its derivative |
| 07/11/2001 | CN1302559A Curcumin preparation |
| 07/11/2001 | CN1068333C Sterol derivatives used as regulation of meiosis |
| 07/11/2001 | CN1068328C Spirocyclic and bicyclic diazinyl and carbazinyl oxazolidinones |
| 07/11/2001 | CN1068327C 2,7-Substituted octahydro-1H-pyrido [1,2-alpha]pyrazin derivatives |
| 07/11/2001 | CN1068326C Tetrazole derivatives, their production and use |
| 07/11/2001 | CN1068325C Phenyloxazolidinone antimicrobials |
| 07/11/2001 | CN1068324C Crystalline substituted benzothiophene hydrochlorate, pharmaceutical preparation and its use |
| 07/11/2001 | CN1068318C 2-Substituted 1,2,5-thiadiazolidin-3-onel, 1-dioxides and compositions and method of use thereof |
| 07/11/2001 | CN1068317C Benzothiazole quinone and its preparing process and use |
| 07/11/2001 | CN1068314C Triazole compounds and their use as dopamine -D3-ligands |
| 07/11/2001 | CN1068308C Substituted benzoylguanide, its preparing process and medicine and application of same |
| 07/11/2001 | CN1068305C Process for preparing S(-)-2-(4-isobutyl-phenyl) with antimer of purity more than 90% |
| 07/11/2001 | CN1068210C Monkshood polysaccharide injection and preparing process thereof |
| 07/11/2001 | CN1068200C 9-cis-isotretinoin and use of its salt and ester medicine |
| 07/11/2001 | CA2295260A1 Method for treating septic shock |
| 07/10/2001 | WO2001051056A1 Fulvestrant formulation |
| 07/10/2001 | US6258953 Arylacrylamide derivatives |
| 07/10/2001 | US6258952 Thermally stable trimetrexates and processes for producing the same |
| 07/10/2001 | US6258951 Chemical compounds |
| 07/10/2001 | US6258948 An n-acylamino compound; antiinflammatory agents, autoimmune diseases |
| 07/10/2001 | US6258946 Chemical intermediate for diuretic |
| 07/10/2001 | US6258945 HIV-1P-17 peptide fragments, compositions containing and methods for producing and using same |
| 07/10/2001 | US6258937 Hepadnavirus receptor |
| 07/10/2001 | US6258929 Amino acid sequence of protein which binds presenilin 1; alzheimer's disease |
| 07/10/2001 | US6258856 Administering estrogen for cataract prevention |
| 07/10/2001 | US6258855 Method of retarding and ameliorating carpal tunnel syndrome |
| 07/10/2001 | US6258854 Ketone ethers for odors |
| 07/10/2001 | US6258853 Drugs as antiserrotonin agents |
| 07/10/2001 | US6258852 Aryl nitrone therapeutics for the treatment of inflammatory bowel disease |
| 07/10/2001 | US6258851 Metalloproteinase inhibitors |
| 07/10/2001 | US6258850 3-aryl-2-hydroxypropionic acid derivative (I) |
| 07/10/2001 | US6258849 Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate |
| 07/10/2001 | US6258848 Methods and compositions for increasing insulin sensitivity |
| 07/10/2001 | US6258847 Use of 2-mercaptoethanolamine (2-MEA) and related aminothiol compounds and copper(II)-3,5 di-isopropyl salicylates and related compounds in the prevention and treatment of various diseases |
| 07/10/2001 | US6258846 Enriching breast milk |
| 07/10/2001 | US6258845 Cancer treatment and antiinflammatory agents |
| 07/10/2001 | US6258844 Hypotensive agents for vision hypertension in mammals |
| 07/10/2001 | US6258843 4-oxy-3-(aryl)phenyl-arylcarbonyloxy compounds useful as phosphodiesterase inhibitors |
| 07/10/2001 | US6258842 Method for the preparation of citalopram |
| 07/10/2001 | US6258839 Isolation of naturally occuring isoflavanone and some clinical uses thereof |
| 07/10/2001 | US6258838 Compounds |
| 07/10/2001 | US6258837 Antagonist in mammals for neuropeptides |
| 07/10/2001 | US6258836 Dopamine analog amide |
| 07/10/2001 | US6258834 Method for prophylaxis and treatment of diabetic complications with 4[α-hydroxy-2-methyl-5-(1-imidazolyl)benzyl]-3,5-dimethylbenzoic acid and derivatives |
| 07/10/2001 | US6258833 Enzyme inhibitors and antiinflammatory agents |
| 07/10/2001 | US6258832 Reduction of compounds with aluminum in aprotic solvent |